Celltrion
068270.KS
#754
Rank
ยฃ20.72 B
Marketcap
ยฃ100.04
Share price
0.72%
Change (1 day)
1.80%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Earnings for Celltrion (068270.KS)

Earnings in 2024 (TTM): ยฃ0.40 Billion

According to Celltrion 's latest financial reports the company's current earnings are ยฃ1.97 Billion. In 2023 the company made an earning of ยฃ0.39 Billion, an increase over its 2022 earnings that were of ยฃ0.37 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Celltrion from 2008 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) ยฃ0.40 B1.84%
2023 ยฃ0.39 B6.8%
2022 ยฃ0.37 B-21.85%
2021 ยฃ0.47 B10.25%
2020 ยฃ0.42 B65.16%
2019 ยฃ0.26 B16.64%
2018 ยฃ0.22 B-33.89%
2017 ยฃ0.33 B106.53%
2016 ยฃ0.16 B25.57%
2015 ยฃ0.13 B-6.54%
2014 ยฃ0.13 B47.36%
2013 ยฃ94.4 M-33.63%
2012 ยฃ0.14 B
2010 ยฃ73.81 M72.84%
2009 ยฃ42.7 M260.54%
2008 ยฃ11.84 M